- Take an Extra 30% Off Any Book: Use promo code HOLIDAY30 at checkout to get an extra 30% off any book for a limited time. Excludes Kindle eBooks and Audible Audiobooks. Restrictions apply. Learn more
Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
To get the free app, enter your email address or mobile phone number.
"Oz should invite LaMattina back on his show. Since LaMattina treats all concerns respectfully, Oz needn’t worry about feeling devalued or distrusted." (Barron's, 5 May 2014)
“This is an honest book by an insider who believes in the basic good that the industry does.” (The Quarterly Review of Biology, 1 September 2013)
“Summing Up: Recommended. General audiences.” (Choice, 1 September 2013)
“For those more loosely associated or aspiring to work with in it, I particularly recommend this book as a balanced and informative read on the pressures the industry faces. It should also provide the basis for more reasoned argument and forewarn anyone else potentially ambushed by a TV show.” (ChemMedChem, 19 July 2013)
“That said, the suggestions made by LaMattina for improvements in productivity and transparency are timely, and the book makes interesting if unexciting reading.” (Chemistry & Industry, 1 June 2013)
“John LaMattina (ex-head of Pfizer's global R&D) has a new book out about the industry, called Devalued and Distrusted. He tells Pharmalot that he got the idea to write a sequel to his earlier book, Drug Truths, when he appeared on the "Dr. Oz" show.” (In The Pipeline, 1 December 2012)
“ … the book is laden with so many facts, critical insights and pearls of wisdom that it deserves the attention of a wide audience, from lay people to professionals in R&D, medicine, government, business and mass media. Dr. LaMatina has performed a public service by drawing on his broad experience to clarify the issues and the many challenges that have to be faced if progress in therapeutic molecular medicine is to continue, and to illuminate the ongoing tensions that are bound to arise with ever increasing risks and costs in pharma and biotech R&D, never-perfect new medicines and constantly rising consumer expectations and government involvement.”—E J Corey, Harvard University
I give this book 5 stars because it moves the discussion forward.
For way to long Big Pharma has been painted the evil villain -- and while they are far from innocent... Read more
I was actually pleasantly surprised by this book. While the author does not resolve all my issues, John L. Read morePublished on August 3, 2013 by Sukru Tikves
Pharma has a bad reputation lately. Especially when we are inundated with hundreds of television or print ads telling us that we NEED to 'ask' our doctor about the prescription. Read morePublished on August 2, 2013 by Christopher Barrett
"Big Pharma", like "big oil", "big box retailers", and "big tobacco", is constantly demonized in the media and in popular culture (seen 'The Constant Gardener'?). Read morePublished on July 24, 2013 by A Customer
John LaMatina is a former employee of Phizer and worked in the R&D division. This short book is written to help explain why major drug companies sell what they sell and why. Read morePublished on July 18, 2013 by Connie
An in-depth and fairly objective narration from a 30-year veteran of the pharmaceutical industry, Mr LaMattina. Read morePublished on July 17, 2013 by Amazon Customer
From the very first page, the author describes an unpleasant surprise as a guest on the Dr. Oz show which may be an anecdote shared to justify this slim volume's misleading title... Read morePublished on July 15, 2013 by vvv
I'm one of those who seldom use any pharmaceutical product, but have felt that the industry might be getting a bum rap from the public. Read morePublished on July 2, 2013 by Neal Reynolds